URSOCHOL

This brand name is authorized in Finland, Germany, Netherlands, Romania, Spain.

Active ingredients

The drug URSOCHOL contains one active pharmaceutical ingredient (API):

1
UNII 724L30Y2QR - URSODIOL
 

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.
 
Read more about Ursodeoxycholic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A05AA02 Ursodeoxycholic acid A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00988856, 02251195, 02251203
ES Centro de información online de medicamentos de la AEMPS 56119
FI Lääkealan turvallisuus- ja kehittämiskeskus 051739
NL Z-Index G-Standaard, PRK 124494, 18384, 77771
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W53024001, W53024002, W53024003, W53024004, W53024005, W53025001, W53025002, W53025003, W53025004, W53025005

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈